GPI pulse is a powerful, revolutionary way of accessing data-driven price and access insights

for the complete market access journey: Better decisions, faster

GPI’s innovative platform

Designed specifically with payer thinking in mind to support informed decisions through insight and analytics. GPI pulse leverages the latest technology to combine multiple data streams of live price and access events, with expanded data and integrated analytic tools for in-depth analysis of pricing, reimbursement, and regulatory activities. GPI pulse enables users to analyze trends, evaluate product value and create competitive advantages.


GPI pulse provides granular information

Drill price, access and HTA data down to individual pack, indication or patient level to rapidly respond to market dynamics. GPI pulse helps you understand how payer bodies perceive pricing & value in their recommendations.

Centralise and integrate data

GPI pulse’s powerful APIs open up endless opportunities to create new workflows, features, and products or integrate with internal platforms. With access to millions of data points, you can build seamless forecasting models, analog analysis, competitor and comparator evaluations, IRP analysis or anything else that strikes your fancy.

Complete confidence in P&R decisions

Best-in-class intelligence, GPI’s innovative platform supports decision-making across geographies by detecting trends and market opportunities

Better insights, better outcomes

One-click access to real-time events through sophisticated tracking functionality and clear visualization capabilities

More time for decision-making

Experience a reduction in internal research hours and the need to commission fewer consulting engagements

About GPI pulse
Where does the data come from?

Combining multiple public and private data sources across 100 countries and sorting through millions of data points, we provide business intelligence from a variety of sources: regulatory, price and reimbursement, dosing schedule, legal filings, technology appraisals and many more.

How is it turned into useful data?

Not all global price and access data is clean, and easy to interpret. By dynamically collecting each data source in real time, we are able to make smart decisions about which data source to use for each attribute. We use clever machine learning to analyze the data and turn it into standardized and usable attributes.

How accurate is the data?

We strive to keep the best data accuracy in the business, every record goes through three stages of verification – ‘3-eyes QA’. 1. The data is checked by machine algorithms. 2. Our data analysts check the data. Unfortunately, not all publicly available data is accurate, and we use a combination of outlier recognition and a highly trained QA team to ensure that every single record is as accurate as possible. 3. The data is sanity checked by a professional pharmacist or health economist ensuring the highest quality information available on the market space.

Our data

GPI pulse has a number of key complete therapy areas with additional areas built to demand. P&R data coverage across 100+ countries and 30 HTA countries including North America, Europe, Latin America, Asia, Africa and Oceania


Over the past two years, our data set and machine learning algorithms have improved to the point where we have the best data in the business, and we’ll prove it. Just get in touch, and we’ll happily provide a complementary data sample for your review.


Price and access data are constantly changing. At any given moment, a dataset, even the very best one, has a finite lifespan. Days or weeks later, things have changed and a percentage of that dataset is no longer valid. To combat this, we mirror the local publication cycle to ensure that you have the most up-to-date data possible. Our data is refreshed within 72 hours of publication – 72 hours are required for stringent 3-eyes QA.


Pulse data provides a multi-dimensional view of your competitor, analog or therapy area through detailed price, access and HTA outcome data helping you optimise the value of drug therapies and empowers you to achieve optimal reimbursement in line with payer value perceptions.

Use Cases
Anticipate Payer Reactions

GPI pulse detects patterns in historical data and events allowing you to anticipate payer decisions and prepare accordingly.

With the GPI pulse’s deep archive of historical data, you will be able to go back in time and see what your competitors were doing at any specific moment in time or understand an analogs route to reimbursement.

Track Landscape Changes

Automate the surveillance of movements in your therapy area and beware of new players.

GPI pulse has an intuitive UI that provides instant alerts on competitor activity and insights into drivers behind the change.

With the GPI pulse’s deep archive of historical data, you will be able to go back in time and see what your competitors were doing at any specific moment in time.

Discover Competitor Movements

GPI pulses’ automated competitor detector is constantly searching for new products using molecule search keywords.

If a new player gets a price or your competitor gets regulatory or reimbursement approval, you will be the first to know about it. Keep your finger on the pulse.

Single Source Of Information

From an intuitive UX/UI that provides instant alerts on competitor activity and insights into drivers behind the change to the use of machine learning to identify trends and patterns, GPI pulse leverage state of the art technology with the goal to a consistent, aligned intelligence and insights with features to share data and collaborate with other members of the team.

Respond Immediately

Protect your strategies from market changes. With real-time alerts, you’re in the best possible position for an effective response to any scenario.

GPI pulse ensures you have the most up-to-date and accurate information at all times and helps you manage your response.

Informing Strategic Decisions

Complete price and access landscape information aids the process of valuing drug therapies and empowers companies to achieve optimal reimbursement for their innovation by comparing data on a like-for-like level.